There are several risks associated with the use of percutaneous AngioJet thrombectomy, none of which are common, but all of which require some knowledge of the issues to prevent complications.
Boston Scientific ($BSX) announced simultaneous approval to market its AngioJet ZelanteDVT thrombectomy catheter for treating deep vein thrombosis in the U.S., Europe ...
Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe MARLBOROUGH, Mass., Boston Scientific has received United States (U.S.) Food and Drug Administration (FDA) approval ...
Intravenous thrombolysis is the treatment of choice in patients presenting with high- and intermediate-risk pulmonary embolism. The role of percutaneous mechanical pulmonary thrombectomy (PMPT) is not ...
SAN FRANCISCO (MarketWatch) -- Possis Medical Inc. said Monday it has received marketing approval from the Food and Drug Administration for its AngioJet Ultra Thrombectomy System, the next-generation ...
Background A 43-year-old African-American female (gravida 5 para 0) with an 8-week intrauterine pregnancy presented to the emergency room with crampy abdominal pain, shortness of breath, and shoulder ...
Boston Scientific Corporation BSX recently won the U.S. Food and Drug Administration’s (FDA) approval and the CE Mark for its AngioJet ZelanteDVT thrombectomy catheter. The regulatory clearances make ...
In the United States, open surgical thrombectomy was largely abandoned in the 1980s owing to the severity of complications associated with its use. [30] The one area where its use remains is in those ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results